222 related articles for article (PubMed ID: 15490720)
1. Beta-2-microglobulin in multiple myeloma.
Musarurwa C; Matarira HT
Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
[No Abstract] [Full Text] [Related]
2. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
Scudla V; Vavrdová V; Budíková M; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
[TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
Kraj M; Maj S; Pogłód R; Rostkowska J
Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of asymptomatic multiple myeloma.
Alexanian R; Barlogie B; Dixon D
Arch Intern Med; 1988 Sep; 148(9):1963-5. PubMed ID: 2458080
[TBL] [Abstract][Full Text] [Related]
7. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: prognostic factors and treatment modalities.
Michiels JJ
Neth J Med; 1992 Jun; 40(5-6):254-70. PubMed ID: 1436263
[No Abstract] [Full Text] [Related]
10. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
Zhong M; Liu W
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
[No Abstract] [Full Text] [Related]
11. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
[TBL] [Abstract][Full Text] [Related]
12. [Classification, staging and prognostic indices for multiple myeloma].
Hotta T
Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
[TBL] [Abstract][Full Text] [Related]
13. [The prognosis of patients with multiple myeloma--the aspect of histological distribution to the renal tissue and serum level of beta 2-MG].
Inoue Y; Suzuki K; Enomoto H; Takemura T; Nakamura K
Rinsho Ketsueki; 1992 Aug; 33(8):1012-6. PubMed ID: 1404855
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in multiple myeloma].
Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A
Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219
[No Abstract] [Full Text] [Related]
15. [Multiple myeloma].
Almazov VA; Afanasév BV; Podoltseva ZI
Klin Med (Mosk); 1993; 71(2):5-10. PubMed ID: 8046926
[No Abstract] [Full Text] [Related]
16. Serum beta 2 microglobulin in multiple myeloma and related plasma cell dyscrasias.
Pasquini E; Tiraferri E; Fattori PP; Fabbri I; Gobbi M
Haematologica; 1987; 72(1):17-21. PubMed ID: 3108090
[No Abstract] [Full Text] [Related]
17. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
[No Abstract] [Full Text] [Related]
18. Clinical impact of discordance in serum albumin measurements on myeloma international staging system.
Kapoor P; Snozek CL; Colby C; Larson DR; Katzmann JA; Rajkumar SV; Greipp PR
J Clin Oncol; 2008 Aug; 26(24):4051-2. PubMed ID: 18711203
[No Abstract] [Full Text] [Related]
19. [Serum levels of beta 2-microglobulin in malignant hemopathies].
López Fernández A; Cuesta B; Rocha E
Sangre (Barc); 1985; 30(3):320-9. PubMed ID: 3898421
[No Abstract] [Full Text] [Related]
20. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
Tichý M; Maisnar V; Palicka V; Friedecký B; Vávrová J; Novotná H; Cermáková Z; Dastych M; Cechák P; Vogtová D; Jarolímková E; Benáková H; Hachová L; Bezdícková D; Kouril F; Zábranská EA; Zenková J; Slabý P; Scudla V; Gregora E; Spicka I; Straub J; Schützova M; Hájek R
Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]